Experimental Alzheimer's drug that fights a tough-to-target protein shows promise at slowing cognitive decline in a clinical trial
- Posted on July 23, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Experimental Alzheimer's drug that fights a tough-to-target protein shows promise at slowing cognitive decline in a clinical trial
An experimental drug might slow early Alzheimer’s disease by targeting a hallmark of the illness that researchers have historically had less success with: toxic tangles of tau proteins inside the brain. Accumulations of these tau tangles and sticky clumps of the protein amyloid beta are the neurodegenerative disease’s defining features. In recent y...
